Characteristics Women (n=6713) Men (n=13502) P Value
Age, median(IQR), y 64 (58-70) 59 (51-66) <0.001
<65, n(%) 3373 (50.25%) 9517 (70.5%) <0.001
65-74, n(%) 2561 (38.15%) 3128 (23.2%) <0.001
≥75, n(%) 779 (11.60%) 857 (6.3%) <0.001
Gender constituent ratio(%) 33.2% 66.8% <0.001
Time in hospital, median(IQR), d 5 (3-7) 5 (3-6) <0.001
Hospital Deaths 2(0.03%) 2(0.01%) 0.476
Paroxysmal AF 4632 (69.0%) 7583 (56.2%) <0.001
Persistent AF 1645 (24.5%) 4918 (36.4%) <0.001
Previous catheter ablation 884 (13.2%) 1764 (13.1%) 0.837
Cryoablation 88 (1.3%) 152 (1.1%) 0.252
Comorbidity, n (%)
Heart failure 242 (3.6%) 345 (2.6%) <0.001
Hypertension 3899 (58.1%) 6551 (48.5%) <0.001
Diabetes mellitus 1079 (16.1%) 2113 (15.6%) 0.436
Stroke/TIA/TE 415 (6.2%) 866 (6.4%) 0.524
Vascular disease 837 (12.5%) 1814 (13.4%) 0.055
Hyperlipemia 1789 (26.6%) 3316 (24.6%) 0.001
Coronary heart disease 1026 (15.3%) 2100 (15.6%) 0.618
Cardiomyopathy 129 (1.9%) 361 (2.7%) 0.001
HCM 120 (1.8%) 240 (1.8%) 0.959
DCM 7 (0.1%) 86 (0.6%) <0.001
Congenital heart disease 36 (0.5%) 40 (0.3%) 0.009
Hyperthyroidism 90 (1.3%) 129 (1.0%) 0.013
Hypothyroidism 317 (4.7%) 249 (1.8%) <0.001
Malignant Tumor 42 (0.6%) 38 (0.3%) <0.001
PAH 24 (0.4%) 29 (0.2%) 0.062
CHA2DS2-VA score 1.64 ± 1.33 1.28 ± 1.26 <0.001
Score=0 1560 (23.2%) 4406 (32.6%) <0.001
Score=1 1811 (27.0%) 4264 (31.6%) <0.001
Score≥2 3342 (49.8%) 4832 (35.8%) <0.001